جست‌وجوی استاد و پژوهشگر

Ilkka Tikkanenمشاهده پروفایل

دانشیار

• Cardiovascular Diseases
• Nephrology
• Hypertension
• +۴ مورد دیگر

Ilkka Tikkanen serves as Docent at the University of Helsinki's Faculty of Medicine, Department of Medicine (Clinicum), and Supervisor for the Doctoral Programme in Biomedicine. He maintains dual affiliations with HUS Abdominal Center and the Unit of Cardiovascular Research at Minerva Institute for Medical Research, Biomedicum Helsinki, focusing on cardiovascular and renal pathophysiology. His research investigates end-organ damage mechanisms in hypertension, heart failure, and renal disease, with emphasis on renin-angiotensin-aldosterone system components, vasoactive factors, and apoptosis. Recent work explores cardiac regeneration post-infarction using molecular and translational approaches, yielding clinically relevant insights into biomarkers and therapeutic targets. Analysis of recent publications (2024-2025) reveals three thematic clusters: molecular cardiology (miRNA biomarkers in shock), genetic determinants of diabetic complications, and experimental models of cardiac function. These span cardiovascular diabetology, interventional cardiology, and molecular biology, demonstrating interdisciplinary integration of clinical and basic research. Scientific Awards: No specific awards are documented in the provided materials, though the Docent title represents significant academic recognition in the Finnish system. Professor Tikkanen actively supervises doctoral candidates (7 theses as supervisor/co-supervisor) and serves on examination committees. His continuous publication record since 2001, including 25+ papers in the last five years, indicates sustained grant funding supporting research in cardiovascular therapeutics and pathophysiology. He leads the Unit of Cardiovascular Research at Minerva Institute, fostering a collaborative environment that bridges clinical practice at HUS with basic science at Biomedicum. The lab emphasizes translational research using zebrafish models, human cohorts, and molecular techniques to address unmet needs in cardiac and renal repair mechanisms.

Erica Wehrweinمشاهده پروفایل

استاد

• Autonomic Nervous System
• Cardiovascular Physiology
• Physiology Education
• +۳ مورد دیگر

Erica Wehrwein serves as a Fixed Term Professor in the Department of Physiology at Michigan State University, where she teaches Human Physiology I (PSL 431) and Capstone Lab in Physiology (PSL 475L). Her academic profile centers on cardiovascular physiology research and innovative physiology education initiatives. Her research interests focus on autonomic nervous system regulation , particularly arterial baroreflex control of blood pressure, carotid body chemoreceptor function during hypoglycemia, and cardiorespiratory coupling mechanisms. She also maintains a robust program in physiology education scholarship , developing national standards for undergraduate physiology degrees, creating hypothesis-driven laboratory curricula, and leading outreach initiatives like PhUn Week events. Wehrwein's publication analysis reveals dual expertise: 60% of her recent work addresses cardiovascular neurophysiology mechanisms (especially baroreflex and chemoreceptor function in glucose homeostasis), while 40% focuses on educational innovations including kinesthetic teaching methods, undergraduate curriculum development, and national physiology program standards. Her research shows strong collaboration with Michael Joyner's team at Mayo Clinic. Wehrwein actively builds academic community through the Physiology Majors Interest Group (PMIG), where she co-organizes annual meetings and develops sustainable outreach models that integrate honors college credits with departmental programs. Her leadership extends to creating large-scale science center events and undergraduate quiz competitions that enhance physiology literacy.

• Renal Physiology
• Vascular Research
• Cardiovascular Pharmacology
• +۳ مورد دیگر

Thomas Jonassen serves as an Associate Professor in the Department of Biomedical Sciences within the Faculty of Health and Medical Sciences at the University of Copenhagen. His research is centered in the Renal and Vascular Research group, where he investigates cardiovascular and renal physiology with particular focus on drug mechanisms and physiological regulation. Jonassen's research interests span renal physiology, vascular function, and pharmacological interventions. His work examines how the kidneys handle sodium under sympathetic stimulation, the effects of drugs like melanocortins and GLP-1 analogs on kidney function, and cardiovascular regulation mechanisms. He employs both basic science approaches using animal models and clinical trial methodologies to translate findings to human applications. Analysis of his recent publications reveals a strong focus on translational research connecting basic physiological mechanisms with clinical applications. His work demonstrates consistent expertise in renal hemodynamics, autonomic regulation of cardiovascular function, and pharmacological interventions for conditions including hypertension, diabetes, and inflammation. The research shows progression from fundamental physiological questions to clinical trials, particularly evident in his 2024 COVID-19 therapeutic study. Jonassen maintains active collaborations with researchers across the University of Copenhagen, particularly with N.-H. Holstein-Rathlou and C. M. Sørensen, demonstrating a strong network within renal and cardiovascular research. His publications have garnered significant attention, with several papers accumulating substantial citations and mentions in social media, news outlets, clinical guidelines, and policy documents.